Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer (Q33376116)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer
scientific article

    Statements

    Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer (English)
    1 reference
    Jeany M Rademaker-Lakhai
    1 reference
    Laurens V Beerepoot
    1 reference
    Niven Mehra
    1 reference
    Sandra A Radema
    1 reference
    Rianne van Maanen
    1 reference
    Joost S Vermaat
    1 reference
    Els O Witteveen
    1 reference
    Carla M Visseren-Grul
    1 reference
    Luna Musib
    1 reference
    Nathan Enas
    1 reference
    Gertjan van Hal
    1 reference
    Emile E Voest
    1 reference
    1 August 2007
    1 reference
    13
    1 reference
    4474-4481
    1 reference
    15 Pt 1
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit